BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3409011)

  • 21. Clinical and neurochemical consequences of neuronal loss in the nucleus basalis of Meynert in Parkinson's disease and Alzheimer's disease.
    Whitehouse PJ
    Adv Neurol; 1987; 45():393-7. PubMed ID: 2881448
    [No Abstract]   [Full Text] [Related]  

  • 22. Neuronal pathology in the nucleus basalis and associated cell groups in senile dementia of the Alzheimer's type: possible role in cell loss.
    Saper CB; German DC; White CL
    Neurology; 1985 Aug; 35(8):1089-95. PubMed ID: 4022341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell loss from the nucleus basalis of Meynert in Alzheimer's disease.
    Doucette R; Fisman M; Hachinski VC; Mersky H
    Can J Neurol Sci; 1986 Nov; 13(4 Suppl):435-40. PubMed ID: 3791059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlative decrease of large neurons in the neostriatum and basal nucleus of Meynert in Alzheimer's disease.
    Oyanagi K; Takahashi H; Wakabayashi K; Ikuta F
    Brain Res; 1989 Dec; 504(2):354-7. PubMed ID: 2598036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis.
    Whitehouse PJ; Price DL; Clark AW; Coyle JT; DeLong MR
    Ann Neurol; 1981 Aug; 10(2):122-6. PubMed ID: 7283399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The nucleus basalis of Meynert in neurological disease: a quantitative morphological study.
    Rogers JD; Brogan D; Mirra SS
    Ann Neurol; 1985 Feb; 17(2):163-70. PubMed ID: 3883886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The nucleus basalis of Meynert in multi-infarct (vascular) dementia.
    Mann DM; Yates PO; Marcyniuk B
    Acta Neuropathol; 1986; 71(3-4):332-7. PubMed ID: 3799146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease.
    Lehéricy S; Hirsch EC; Cervera-Piérot P; Hersh LB; Bakchine S; Piette F; Duyckaerts C; Hauw JJ; Javoy-Agid F; Agid Y
    J Comp Neurol; 1993 Apr; 330(1):15-31. PubMed ID: 8468401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. m2 muscarinic acetylcholine receptor-immunoreactive neurons are not reduced within the nucleus basalis in Alzheimer's disease: relationship with cholinergic and galaninergic perikarya.
    Mufson EJ; Jaffar S; Levey AI
    J Comp Neurol; 1998 Mar; 392(3):313-29. PubMed ID: 9511920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Morphometric study on the CH4 of the nucleus basalis of Meynert in Alzheimer's disease.
    Kobayashi K; Miyazu K; Fukutani Y; Nakamura I; Yamaguchi N
    Mol Chem Neuropathol; 1991 Dec; 15(3):193-206. PubMed ID: 1725482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuropathological changes in the nucleus basalis correlate with clinical measures of dementia.
    Iraizoz I; Guijarro JL; Gonzalo LM; de Lacalle S
    Acta Neuropathol; 1999 Aug; 98(2):186-96. PubMed ID: 10442559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distribution of beta-nerve growth factor receptors in the human basal forebrain.
    Allen SJ; Dawbarn D; Spillantini MG; Goedert M; Wilcock GK; Moss TH; Semenenko FM
    J Comp Neurol; 1989 Nov; 289(4):626-40. PubMed ID: 2556457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The nucleus basalis in Huntington's disease.
    Clark AW; Parhad IM; Folstein SE; Whitehouse PJ; Hedreen JC; Price DL; Chase GA
    Neurology; 1983 Oct; 33(10):1262-7. PubMed ID: 6225032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A sex difference and no effect of ApoE type on the amount of cytoskeletal alterations in the nucleus basalis of Meynert in Alzheimer's disease.
    Salehi A; Gonzalez Martinez V; Swaab DF
    Neurobiol Aging; 1998; 19(6):505-10. PubMed ID: 10192208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease.
    Gilmor ML; Erickson JD; Varoqui H; Hersh LB; Bennett DA; Cochran EJ; Mufson EJ; Levey AI
    J Comp Neurol; 1999 Sep; 411(4):693-704. PubMed ID: 10421878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholinergic circuitry of the human nucleus basalis and its fate in Alzheimer's disease.
    Mesulam MM
    J Comp Neurol; 2013 Dec; 521(18):4124-44. PubMed ID: 23852922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Alzheimer's disease and Meynert's nucleus basalis. An anatomo- clinical point of view].
    Brion S; Plas J; Massé G
    Encephale; 1986; 12(3):111-4. PubMed ID: 3769856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormalities of the nucleus basalis in Down's syndrome.
    Casanova MF; Walker LC; Whitehouse PJ; Price DL
    Ann Neurol; 1985 Sep; 18(3):310-3. PubMed ID: 2932050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pick's disease (lobar sclerosis): depletion of neurons in the nucleus basalis of Meynert.
    Uhl GR; Hilt DC; Hedreen JC; Whitehouse PJ; Price DL
    Neurology; 1983 Nov; 33(11):1470-3. PubMed ID: 6685239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurofibrillary degeneration of cholinergic and noncholinergic neurons of the basal forebrain in Alzheimer's disease.
    Rasool CG; Svendsen CN; Selkoe DJ
    Ann Neurol; 1986 Oct; 20(4):482-8. PubMed ID: 3539000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.